<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24565" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Lymphedema</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sleigh</surname>
            <given-names>Bryan C.</given-names>
          </name>
          <aff>Mercer University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Manna </surname>
            <given-names>Biagio</given-names>
          </name>
          <aff>RWJUH/Barnabas Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bryan Sleigh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Biagio Manna declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24565.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Lymphedema is a chronic disease marked by the increased collection of lymphatic fluid in the body, causing swelling, which can lead to skin and tissue changes. The chronic, progressive accumulation of protein-rich fluid within the interstitium and the fibro-adipose tissue exceeds the capacity of the lymphatic system to transport the fluid. Swelling associated with lymphedema can occur anywhere in the body, including the arms, legs, genitals, face, neck, chest wall, and oral cavity. There are many psychological, physical, and social sequelae related to a diagnosis of lymphedema. This activity reviews the presentation of lymphedema and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of lymphedema.</p></list-item><list-item><p>Review the presentation of lymphedema.</p></list-item><list-item><p>Summarize the treatment options for lymphedema.</p></list-item><list-item><p>Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by lymphedema.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24565&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24565">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24565.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Lymphedema is a chronic disease marked by the increased collection of lymphatic fluid in the body, causing swelling, which can lead to skin and tissue changes. The chronic, progressive accumulation of protein-rich fluid within the interstitium and the fibro-adipose tissue exceeds the capacity of the lymphatic system to transport the fluid. Swelling associated with lymphedema can occur anywhere in the body, including the arms, legs, genitals, face, neck, chest wall, and oral cavity. There are many psychological, physical, and social sequelae related to a diagnosis of lymphedema.&#x000a0;Lymphedema&#x000a0;is classified as either (genetic) primary lymphedema or (acquired) secondary lymphedema.</p>
        <p>The lymphatic vessels transport lymph. Lymph&#x000a0;is composed&#x000a0;of white blood cells, triglycerides, bacteria, cell debris, water, and protein. It has a composition comparable to blood plasma. The lymph drainage system is complex and comprises initial lymphatics (lymph capillaries), pre-collectors, collectors, lymphatic trunks, and lymph nodes.&#x000a0; Topographically, the lymph system is&#x000a0;distinguished as superficial (subcutaneous) and deep (subfascial). The superficial system drains the skin and subcutis areas. The deep system drains muscles, joints, tendon sheaths, and nerves. Both systems are connected via the perforating vessels, which conduct lymph fluid from the subfascial areas to the surface.</p>
        <p>Signs and symptoms of lymphedema include distal swelling in the extremities, including the arms, hands, legs, feet; swelling proximally in the breast, chest, shoulder, pelvis, groin, genitals, face/intraoral tissues; restricted range of motion in the joints because of swelling and tissue changes; skin discoloration; pain and altered sensation; limb heaviness; and difficulty fitting into clothing.</p>
      </sec>
      <sec id="article-24565.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Primary lymphedema&#x000a0;is an&#x000a0;inherited&#x000a0;or congenital condition that causes a malformation of the lymphatics system, most often because of genetic mutation. Primary lymphedema can be subdivided into 3 categories:&#x000a0;1) congenital lymphedema, present at birth or recognized within two years of birth; 2) lymphedema praecox, occurring at puberty or the beginning of the third decade; or 3) lymphedema tarda, which begins after 35 years of age.&#x000a0;</p>
        <p>Secondary lymphedema results from insult, injury, or obstruction to the lymphatic system. While the most common cause of lymphedema worldwide is filariasis caused by infection by <italic toggle="yes">Wuchereria bancrofti</italic>, in developed countries, most secondary lymphedema cases are due to malignancy or related to the treatment of malignancy.&#x000a0;This includes surgical excision of lymph nodes, local radiation treatment, or medical therapy. Breast cancer is the most common cancer associated with secondary lymphedema in developed countries.</p>
      </sec>
      <sec id="article-24565.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Primary lymphedema is rare, affecting 1 in 100,000 individuals.&#x000a0;Secondary lymphedema is the most common cause of the disease and affects approximately 1 in 1000 Americans.</p>
        <p>The identification of the incidence and prevalence of lymphedema is complex. Lymphedema&#x000a0;is remarkably prevalent, but the population implications of lymphatic dysfunction are not well studied. Prevalence estimates for lymphedema are relatively high, yet its prevalence is likely underestimated. There is an absence of prospectively designed and rigorously performed relevant epidemiologic studies that limit the true prevalence&#x000a0;of the disease.<xref ref-type="bibr" rid="article-24565.r1">[1]</xref></p>
        <p>The incidence of lymphedema is most widely studied in the oncologic population. One in 5 women who survive breast cancer will develop lymphedema.<xref ref-type="bibr" rid="article-24565.r2">[2]</xref>&#x000a0;In head and neck cancer, lymphatic and soft tissue complications can develop throughout the first 18 months post-treatment, with greater than 90% of patients experiencing some form of internal, external, or combined lymphedema. Over half of those patients developing fibrosis.<xref ref-type="bibr" rid="article-24565.r3">[3]</xref>&#x000a0;In one recent study, 37% of women treated for gynecological cancer had measurable evidence of lymphedema within 12 months post-treatment.<xref ref-type="bibr" rid="article-24565.r4">[4]</xref>&#x000a0;In the gynecologic oncologic population, more extensive lymph node dissection, receipt of chemotherapy and radiation therapy, increasing body mass index, insufficient levels of physical activity, a diagnosis of vulvar/vaginal cancer, and presence of pre-treatment lymphedema were identified as potential risk factors to lymphedema development.<xref ref-type="bibr" rid="article-24565.r4">[4]</xref></p>
      </sec>
      <sec id="article-24565.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Primary lymphedema&#x000a0;is associated with dysplasia of the lymphatic system and can also develop with conditions of other vascular abnormalities, including Klippel-Trenaunay-Weber syndrome,<xref ref-type="bibr" rid="article-24565.r5">[5]</xref>, and Turner syndrome.<xref ref-type="bibr" rid="article-24565.r6">[6]</xref>&#x000a0;Primary lymphedema is marked by hyperplasia, hypoplasia, or aplasia of the lymphatic vessels.</p>
        <p>Secondary lymphedema develops due to damage or dysfunction of the normally functioning lymphatic system. Although cancer treatments, including oncologic surgical procedures such as axillary lymph node dissection and excision in breast cancer and radiation treatment, are the most common cause of lymphedema in the United States, filariasis is the most common cause of secondary lymphedema globally.<xref ref-type="bibr" rid="article-24565.r7">[7]</xref>&#x000a0;Filariasis is the direct infestation of lymph nodes by the parasite, <italic toggle="yes">Wuchereria bancrofti</italic>.&#x000a0;The&#x000a0;spread of the parasite by mosquitos affects millions of people in the tropic and subtropic regions of Asia, Africa, the Western Pacific, and Central and South America.</p>
        <p>Oncologic surgical procedures such as&#x000a0;sentinel&#x000a0;lymph node biopsy and radical dissection&#x000a0;that require excision of regional lymph nodes or vessels can lead to the development of secondary lymphedema. Other surgical procedures linked to secondary lymphedema development include peripheral vascular surgery, burn scar excision, vein stripping, and lipectomy.</p>
        <p>Nonsurgical causes of lymphedema include recurrent tumors&#x000a0;or malignancy that have&#x000a0;metastasized to the lymph nodes; obstructive lesions within the lymphatic system; infected and/or traumatized lymphatic vessels; scar tissue obliterating the lumen of the lymphatic vessels. Edema from deep venous thrombosis (DVT) or nonobstructive causes of chronic venous insufficiency at the extremities may lead to secondary lymphedema.</p>
        <p>Although there is no definitive cure for lymphedema, with proper diagnosis and management, its progression and potential complications can successfully be managed.<xref ref-type="bibr" rid="article-24565.r8">[8]</xref></p>
      </sec>
      <sec id="article-24565.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>There is no&#x000a0;pathognomonic&#x000a0;histologic finding for lymphedema but may include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Dermal edema (earlier stages)</p>
          </list-item>
          <list-item>
            <p>Hyperkeratosis</p>
          </list-item>
          <list-item>
            <p>Epidermal papillomatosis and hyperplasia</p>
          </list-item>
          <list-item>
            <p>Telangiectatic: dermal vessels with a thickened wall</p>
          </list-item>
          <list-item>
            <p>Thickened upper dermis with fibrillar collagen and an increased number of fibroblasts</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24565.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A thorough history and physical is paramount&#x000a0;in differentiating primary from secondary lymphedema as the 2 are very similar. Primary lymphedema is congenital, and secondary lymphedema results from&#x000a0;insult, injury, or obstruction. A detailed history of duration, distribution, infections, foreign travel, cancer, liver dysfunction, cardiac dysfunction, and prior surgery, especially with lymph node dissection, is critical.</p>
        <p>In its early stages, lymphedema often resembles general edema and is frequently&#x000a0;dismissed as a simple swelling or edema. In lymphedema,&#x000a0;the elevation of the extremity or diuretic therapy is inadequate and does not resolve the swelling. During the beginning stages, pitting is clear, the skin is soft, and limb elevation assists in resolving the edema.&#x000a0;As the disease progresses, pitting ceases to be visible, the skin hardens, and elevation does not relieve the swelling.<xref ref-type="bibr" rid="article-24565.r9">[9]</xref>&#x000a0;Lymphedema can&#x000a0;be&#x000a0;stigmatizing and cause the patient, significant emotional distress. The risk of developing secondary lymphedema is ongoing, and the lymphedema symptoms may not develop until many years later.</p>
        <p>
<bold>History</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Thorough family history&#x000a0;is essential if primary lymphedema&#x000a0;is suspected. It is important to evaluate if other family members, usually from an earlier generation, suffer or have suffered from swollen feet, ankles, and&#x000a0;legs&#x000a0;due to&#x000a0;an&#x000a0;&#x0201c;unknown cause.&#x0201d;</p>
          </list-item>
          <list-item>
            <p>Cancer</p>
          </list-item>
          <list-item>
            <p>Injuries</p>
          </list-item>
          <list-item>
            <p>Severe burns</p>
          </list-item>
        </list>
        <p>
<bold>Signs and Symptoms</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Edema, especially of an extremity</p>
          </list-item>
          <list-item>
            <p>Hyperkeratosis: skin becomes scaly and thickens</p>
          </list-item>
          <list-item>
            <p>Lymphangioma: small blisters and bumps develop on the skin</p>
          </list-item>
          <list-item>
            <p>Lymphorrhea: lymph fluid leaks from the skin</p>
          </list-item>
        </list>
        <p>
<bold>Physical Exam</bold>
</p>
        <p>Skin</p>
        <list list-type="bullet">
          <list-item>
            <p>Dryness, increased thickness, hyperkeratosis, lymphangiomas (blisters containing lymph fluid), abnormally warm or hot, unusually dark skin, and any nodules are all lymphedema indicators.</p>
          </list-item>
          <list-item>
            <p>Papillomatosis, a cobblestone appearance of the skin, may also be present; it results from dilated and distended lymph vessels enveloped in fibrotic tissue.<xref ref-type="bibr" rid="article-24565.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Hyperkeratosis</p>
          </list-item>
          <list-item>
            <p>Lymphangioma</p>
          </list-item>
          <list-item>
            <p>Lymphorrhea</p>
          </list-item>
          <list-item>
            <p>Positive Stemmer's sign: inability to pinch a fold of skin at the root of the second toe suggests&#x000a0;lymphedema<xref ref-type="bibr" rid="article-24565.r10">[10]</xref></p>
          </list-item>
        </list>
        <p>Extremity</p>
        <list list-type="bullet">
          <list-item>
            <p>Size: Less than a 20% difference&#x000a0;in the affected extremity&#x000a0;is&#x000a0;considered&#x000a0;mild or moderate, and greater than 20%&#x000a0;is considered severe.<xref ref-type="bibr" rid="article-24565.r11">[11]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24565.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Lymphedema is often&#x000a0;confused with other causes of extremity edema and enlargement. Understanding the risk factors and physical examination signs of lymphedema can accurately diagnose&#x000a0;patients about 90% of the time. Correct diagnosis is imperative so patients can be managed appropriately.<xref ref-type="bibr" rid="article-24565.r12">[12]</xref>&#x000a0;Diagnosis is suspected by evaluating the history and physical examination. Lymphoscintigraphy confirms the diagnosis.<xref ref-type="bibr" rid="article-24565.r13">[13]</xref></p>
        <p>Blood, urine, or tissue studies are not needed to make the diagnosis. These tests might help to define the underlying causes of lower extremity edema when the etiology is unclear. If&#x000a0;a renal&#x000a0;or hepatic cause is suspected,&#x000a0;liver function, blood urea nitrogen (BUN)/creatinine levels, and urinalysis results should be checked. Neoplastic markers may&#x000a0;be checked&#x000a0;if suspected. Complete&#x000a0;blood count (CBC) with differential should&#x000a0;be checked if an infection is considered.</p>
        <p>Imaging is unnecessary to make the diagnosis but can be used as&#x000a0;confirmation, assessment of the extent of involvement, and help determine therapeutic intervention.</p>
        <p>Lymphoscintigraphy is a procedure that uses&#x000a0;a small amount of radioactive protein-dye&#x000a0;is injected into the web space between the first and second digits of the affected limb. The limb is imaged with a gamma camera to observe the dye as it moves through the lymphatic system.&#x000a0;Images showing dye outside the lymphatic structures suggest edema of lymphatic origin.<xref ref-type="bibr" rid="article-24565.r10">[10]</xref></p>
        <p>Newer technologies include 3-dimensional magnetic resonance imaging (MRI), computerized tomography (CT), ultrasound,&#x000a0;and bioelectrical impedance analysis. Ultrasound is useful to exclude other etiologies like DVT, venous insufficiency and can also help in identifying tissue changes and masses that might be the cause of lymphatic compression. CT and MRI can investigate soft tissue edema with good sensitivity and specificity, but they are relatively expensive.<xref ref-type="bibr" rid="article-24565.r14">[14]</xref></p>
      </sec>
      <sec id="article-24565.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Lymphedema is a progressive disease, and early diagnosis and treatment are paramount. Therefore, it is critical to diagnose and treat both mild and early onset cases to halt the progression of this lifelong and often debilitating condition. For patients to improve their knowledge base and learn helpful evidence-based management and coping strategies, patients must be referred to a specialist holding certification in lymphedema treatment and management. This specialist may be a physician, an occupational therapist, or a physical therapist.&#x000a0;</p>
        <p>
<bold>Therapy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Decongestive lymphedema therapy (DLT): Is the primary treatment for moderate-to-severe lymphedema and mobilizes lymph and dissipates fibrosclerotic tissue.&#x000a0;<xref ref-type="bibr" rid="article-24565.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Manual lymph drainage (MLD): Light lymph massage designed to increase lymph flow</p>
          </list-item>
          <list-item>
            <p>Compression: Helps with drainage, but the improper application can result in skin irritation and increase the risk of infection</p>
          </list-item>
          <list-item>
            <p>Skincare: Fastidious skin care is essential to prevent secondary skin infections</p>
          </list-item>
          <list-item>
            <p>Exercise: Light exercise promotes lymph drainage and protein absorption&#x000a0;via muscle contraction.</p>
          </list-item>
          <list-item>
            <p>Drug therapy: Adjunctive only for pain control or secondary infection</p>
          </list-item>
          <list-item>
            <p>Surgery
<list list-type="bullet"><list-item><p>Debulking&#x000a0;is often ineffective<xref ref-type="bibr" rid="article-24565.r16">[16]</xref></p></list-item><list-item><p>Microsurgical&#x000a0;techniques
<list list-type="bullet"><list-item><p>Vascularized&#x000a0;Lymph Node Transfer (VLNT)</p></list-item><list-item><p>Lymphaticovenous&#x000a0;Anastomoses (LVA): VLNT and LVA are microsurgical procedures that can improve the patient's physiologic drainage of the lymphatic fluid and eliminate the need for compression garments in some patients.&#x000a0;These procedures have better results when performed when a patient's lymphatic system has less damage.</p></list-item><list-item><p>Suction-Assisted Protein Lipectomy (SAPL): Is more effective in later stages of lymphedema and&#x000a0;allow removal of lymphatic solids and fatty deposits that are poor candidates for conservative lymphedema therapy or VLNT or LVA surgeries<xref ref-type="bibr" rid="article-24565.r17">[17]</xref><xref ref-type="bibr" rid="article-24565.r18">[18]</xref></p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24565.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Congestive heart failure</p>
          </list-item>
          <list-item>
            <p>Glomerulonephritis</p>
          </list-item>
          <list-item>
            <p>Nephrotic syndrome</p>
          </list-item>
          <list-item>
            <p>Hypoproteinemia</p>
          </list-item>
          <list-item>
            <p>Drug reactions</p>
          </list-item>
          <list-item>
            <p>Cirrhosis of the liver</p>
          </list-item>
          <list-item>
            <p>Pretibial myxedema</p>
          </list-item>
          <list-item>
            <p>Constrictive pericarditis</p>
          </list-item>
          <list-item>
            <p>Lower limb dependency syndrome</p>
          </list-item>
          <list-item>
            <p>Lipedema</p>
          </list-item>
          <list-item>
            <p>Bilateral chronic venous insufficiency</p>
          </list-item>
          <list-item>
            <p>Malignancy</p>
          </list-item>
          <list-item>
            <p>DVT</p>
          </list-item>
          <list-item>
            <p>Malignant lymphedema</p>
          </list-item>
          <list-item>
            <p>Postoperative complications following surgery</p>
          </list-item>
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Baker cyst</p>
          </list-item>
          <list-item>
            <p>Cyclical and idiopathic edema<xref ref-type="bibr" rid="article-24565.r19">[19]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Arthritis in children&#x000a0;is associated with&#x000a0;lower limb swelling, but the underlying mechanism is unknown.<xref ref-type="bibr" rid="article-24565.r20">[20]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24565.s11" sec-type="Staging">
        <title>Staging</title>
        <p>
<bold>Lymphedema Stages</bold>
</p>
        <p>
<bold>Stage 0&#x000a0;(Latency stage)&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The patient is considered &#x0201c;at-risk&#x0201d; for lymphedema development due to injury to the lymphatic vessels but does not present with outward signs of edema.</p>
          </list-item>
          <list-item>
            <p>Includes patients with breast cancer who have undergone sentinel lymph node biopsy and&#x000a0;or radiation but have not yet developed swelling.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Lymphatic transport capacity has&#x000a0;been reduced, which predisposes the patient to lymphatic overload and resultant edema.</p>
          </list-item>
        </list>
        <p>
<bold>Stage 1&#x000a0;(Spontaneous)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Reversible</p>
          </list-item>
          <list-item>
            <p>Has pitting edema</p>
          </list-item>
          <list-item>
            <p>Swelling at this stage is soft and may respond to elevation</p>
          </list-item>
        </list>
        <p>
<bold>Stage 2&#x000a0;(Spontaneously irreversible)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Has tissue fibrosis/induration</p>
          </list-item>
          <list-item>
            <p>Swelling does not respond to elevation</p>
          </list-item>
          <list-item>
            <p>Skin and tissue thickening occurs as the limb volume increases</p>
          </list-item>
          <list-item>
            <p>Pitting may be present but may be difficult to assess&#x000a0;due to tissue and or skin fibrosis</p>
          </list-item>
        </list>
        <p>
<bold>Stage 3&#x000a0;(Lymphostatic elephantiasis)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Show&#x000a0;the following:
<list list-type="bullet"><list-item><p>Pitting edema</p></list-item><list-item><p>Fibrosis</p></list-item><list-item><p>Skin changes</p></list-item><list-item><p>During this stage, papillomas may form, infections/cellulitis may occur, and the skin becomes dry</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>&#x000a0;The Stemmer sign may not be present in Stages 1 or 2.</p>
      </sec>
      <sec id="article-24565.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>A cure is rarely achieved once lymphedema occurs. Meticulous treatment and preventive measures&#x000a0;can help lessen symptoms, slow or stop disease progression, and prevent complications. Patients with chronic lymphedema for ten years have a 10% risk of developing lymphangiosarcoma. This tumor is highly aggressive, requires radical amputation of the involved extremity, and has a very poor prognosis. Five-year survival is less than 10%.<xref ref-type="bibr" rid="article-24565.r21">[21]</xref></p>
      </sec>
      <sec id="article-24565.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of lymphedema also include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cellulitis: often recurrent</p>
          </list-item>
          <list-item>
            <p>Lymphangitis</p>
          </list-item>
          <list-item>
            <p>Superficial bacterial and fungal infections</p>
          </list-item>
          <list-item>
            <p>Lymphangio-adenitis</p>
          </list-item>
          <list-item>
            <p>Deep vein thrombosis (DVT)</p>
          </list-item>
          <list-item>
            <p>Severe functional impairment</p>
          </list-item>
          <list-item>
            <p>Psychosocial dysfunction</p>
          </list-item>
          <list-item>
            <p>Cosmetic embarrassment</p>
          </list-item>
          <list-item>
            <p>Amputation</p>
          </list-item>
          <list-item>
            <p>Complications following surgery are common and include:
<list list-type="bullet"><list-item><p>Partial wound separation</p></list-item><list-item><p>Seroma</p></list-item><list-item><p>Hematoma</p></list-item><list-item><p>Skin necrosis</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24565.s14" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Oncology for neoplasm</p>
          </list-item>
          <list-item>
            <p>Infectious&#x000a0;disease for recurrent cellulitis or complex infections</p>
          </list-item>
          <list-item>
            <p>Referral for rehabilitation services with a certified lymphedema therapist (CLT)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24565.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>
<bold>Education</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Self MLD</p>
          </list-item>
          <list-item>
            <p>Infection prevention</p>
          </list-item>
          <list-item>
            <p>Exercise</p>
          </list-item>
          <list-item>
            <p>Weight control</p>
          </list-item>
          <list-item>
            <p>Use of compression garments</p>
          </list-item>
          <list-item>
            <p>Avoid venipuncture in the affected extremity</p>
          </list-item>
          <list-item>
            <p>Avoidance of other constricting items; do not take BP measurements on the affected extremity</p>
          </list-item>
        </list>
        <p>
<bold>Support</bold>
</p>
        <p>There are numerous support groups and resources that can be found on the National Lymphedema Network website.</p>
      </sec>
      <sec id="article-24565.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Lymphedema is quite common, but the diagnosis and treatment are complex. The majority of patients with lymphedema first present to the primary care provider. These professionals should be aware of the diagnosis of lymphedema and know the causes. While most cases are benign, the condition may be caused by an underlying malignancy.</p>
        <p>An interprofessional team is recommended to achieve the best lymphedema management and care. The first step is recognition and early diagnosis, often by a primary care physician or nurse practitioner. Since most cases&#x000a0;are related to neoplasm and post-surgical issues, surgeons and oncologists with a solid foundation in lymphedema recognition, prevention and,&#x000a0;treatment are essential. The addition of a certified lymphedema therapist rounds out the&#x000a0;team.</p>
        <p>The pharmacist should educate the patient on compression stockings or garments. Irrespective of treatment, compression stockings make a major difference in the swelling. Many patients do become anxious or depressed because of poor aesthetics, and hence, a mental health nurse should counsel them.</p>
        <p>There is no cure for lymphedema, and treatment is lifelong. Depending on which extremity is involved, the condition can affect function and quality of life. Rigid adherence to compression stockings is mandatory to obtain relief from the pain and swelling. In addition, skin dryness and pruritus also need to be addressed. All patients should be seen by a wound care nurse if there is tissue breakdown. At this point, the chances of healing are small, and daily wound dressings are necessary.</p>
      </sec>
      <sec id="article-24565.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24565&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24565">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/lymphedema/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24565">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24565/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24565">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24565.s18">
        <fig id="article-24565.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Lymphedema 
Stage 4 Lymphedema; note the skin changes, edema, fibrosis, and papillomas. Contributed by Mark A. Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Lymphedema__Stage__4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24565.s19">
        <title>References</title>
        <ref id="article-24565.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rockson</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Estimating the population burden of lymphedema.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2008</year>
            <volume>1131</volume>
            <fpage>147</fpage>
            <page-range>147-54</page-range>
            <pub-id pub-id-type="pmid">18519968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DiSipio</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rye</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.</article-title>
            <source>Lancet Oncol</source>
            <year>2013</year>
            <month>May</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>500</fpage>
            <page-range>500-15</page-range>
            <pub-id pub-id-type="pmid">23540561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ridner</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Dietrich</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Niermann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cmelak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mannion</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>A Prospective Study of the Lymphedema and Fibrosis Continuum in Patients with Head and Neck Cancer.</article-title>
            <source>Lymphat Res Biol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>198</fpage>
            <page-range>198-205</page-range>
            <pub-id pub-id-type="pmid">27305456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayes</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Janda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Reul-Hirche</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cornish</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Obermair</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors.</article-title>
            <source>Gynecol Oncol</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>146</volume>
            <issue>3</issue>
            <fpage>623</fpage>
            <page-range>623-629</page-range>
            <pub-id pub-id-type="pmid">28624154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andraska</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Horne</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Eliason</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wakefield</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Patterns of pediatric venous disease.</article-title>
            <source>J Vasc Surg Venous Lymphat Disord</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>422</fpage>
            <page-range>422-5</page-range>
            <pub-id pub-id-type="pmid">27638996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cazzolla</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Lo Muzio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Di Fede</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lacarbonara</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Colaprico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Testa</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Giuseppe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhurakivska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Marzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lacaita</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Orthopedic-orthodontic treatment of the patient with Turner's syndrome: Review of the literature and case report.</article-title>
            <source>Spec Care Dentist</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>239</fpage>
            <page-range>239-248</page-range>
            <pub-id pub-id-type="pmid">29846955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slater</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Gambhir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parham</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Michael</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Modelling co-infection with malaria and lymphatic filariasis.</article-title>
            <source>PLoS Comput Biol</source>
            <year>2013</year>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>e1003096</fpage>
            <pub-id pub-id-type="pmid">23785271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grada</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Lymphedema: Pathophysiology and clinical manifestations.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>1009</fpage>
            <page-range>1009-1020</page-range>
            <pub-id pub-id-type="pmid">29132848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>King</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of lymphoedema.</article-title>
            <source>Nurs Times</source>
            <string-date>2006 Mar 28-Apr 3</string-date>
            <volume>102</volume>
            <issue>13</issue>
            <fpage>47</fpage>
            <page-range>47, 49, 51</page-range>
            <pub-id pub-id-type="pmid">16605153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mortimer</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Swollen lower limb-2: lymphoedema.</article-title>
            <source>BMJ</source>
            <year>2000</year>
            <month>Jun</month>
            <day>03</day>
            <volume>320</volume>
            <issue>7248</issue>
            <fpage>1527</fpage>
            <page-range>1527-9</page-range>
            <pub-id pub-id-type="pmid">10834903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lund</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Exploring the use of CircAid legging in the management of lymphoedema.</article-title>
            <source>Int J Palliat Nurs</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>383</fpage>
            <page-range>383-91</page-range>
            <pub-id pub-id-type="pmid">12411850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greene</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Goss</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Staging of Lymphedema.</article-title>
            <source>Semin Plast Surg</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-16</page-range>
            <pub-id pub-id-type="pmid">29636648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maclellan</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Lymphedema.</article-title>
            <source>Semin Pediatr Surg</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>191</fpage>
            <page-range>191-7</page-range>
            <pub-id pub-id-type="pmid">25241097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biglia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zanfagnin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Daniele</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Robba</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bounous</surname>
                <given-names>VE</given-names>
              </name>
            </person-group>
            <article-title>Lower Body Lymphedema in Patients with Gynecologic Cancer.</article-title>
            <source>Anticancer Res</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>4005</fpage>
            <page-range>4005-4015</page-range>
            <pub-id pub-id-type="pmid">28739682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Getz</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>The primary, secondary, and tertiary nursing interventions of lymphedema.</article-title>
            <source>Cancer Nurs</source>
            <year>1985</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-84</page-range>
            <pub-id pub-id-type="pmid">3849341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warren</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Brorson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Borud</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Slavin</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Lymphedema: a comprehensive review.</article-title>
            <source>Ann Plast Surg</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>464</fpage>
            <page-range>464-72</page-range>
            <pub-id pub-id-type="pmid">17901744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Granzow</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Lymphedema surgery: the current state of the art.</article-title>
            <source>Clin Exp Metastasis</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>5-6</issue>
            <fpage>553</fpage>
            <page-range>553-558</page-range>
            <pub-id pub-id-type="pmid">29980891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Granzow</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Suction Assisted Protein Lipectomy (SAPL) Even for the Treatment of Chronic Fibrotic and Scarified Lower Extremity Lymphedema.</article-title>
            <source>Lymphology</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-41</page-range>
            <pub-id pub-id-type="pmid">29906063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tiwari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Button</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Myint</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis, investigation, and current treatment of lower limb lymphedema.</article-title>
            <source>Arch Surg</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-61</page-range>
            <pub-id pub-id-type="pmid">12578410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bardare</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Falcini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hertzberger-ten Cate</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Savolainen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cimaz</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic limb edema in children with chronic arthritis: a multicenter report of 12 cases.</article-title>
            <source>J Rheumatol</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>384</fpage>
            <page-range>384-8</page-range>
            <pub-id pub-id-type="pmid">9035001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24565.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farhat</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Le Guern</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peugniez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dabouz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Quinchon</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Modiano</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Angiosarcoma in primary lymphoedema: A rare complication].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>145</volume>
            <issue>4</issue>
            <fpage>266</fpage>
            <page-range>266-269</page-range>
            <pub-id pub-id-type="pmid">29530502</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
